Abstract:Tumor is one of the most serious threats for human being. Although many anti-tumor drugs are approved for clinical use, the treatment outcome is still modest because of the poor tumor targeting efficiency and low accumulation in tumor. Therefore, it is important to deliver anti-tumor drug into tumor efficiently, elevate drug concentration in tumor tissues and reduce the drug distribution in normal tissues. And it has been one of the most attractive directions of pharmaceutical academy and industry. Many kinds of strategies, especially various nanoparticulated drug delivery systems, have been developed to address the critical points of complex tumor microenvironment, which are partially or mostly satisfied for tumor treatment. In this paper, we carefully reviewed the novel targeting delivery strategies developed in recent years. The most powerful method is passive targeting delivery based on the enhanced permeability and retention(EPR) effect, and most commercial nanomedicines are based on the EPR effect. However, the high permeability and retention require different particle sizes, thus several kinds of size-changeable nanoparticles are developed, such as size reducible particles and assemble particles, to satisfy the controversial requirement for particle size and enhance both tumor retention and penetration. Surface charge reversible nanoparticles also shows a high efficiency because the anionic charge in blood circulation and normal organs decrease the unintended internalization. The charge can change into positive in tumor microenvironment, facilitating drug uptake by tumor cells. Additionally, tumor microenvironment responsive drug release is important to decrease drug side effect, and many strategies are developed, such as p H sensitive release and enzyme sensitive release. Except the responsive nanoparticles, shaping tumor microenvironment could attenuate the barriers in drug delivery, for example, decreasing tumor collagen intensity and normalizing tumor microvessels to decrease the internal fluid pressure. All these strategies could enhance the accumulation and penetration of nanoparticles into tumor, leading to a homogenous distribution of drugs in tumor. To enhance the internalization by specific cells, active targeting delivery strategies are developed. There were many surface markers, receptors or carriers overexpressed on specific kinds of cells, thus the corresponding ligands were utilized to mediate active targeting to certain cells, including tumor cells, cancer stem cells, tumor neovasculatures, tumor associated macrophages and other tumor stroma cells. Targeting more than one cell type may provide an improved antitumor effect. Although these passive and active targeting strategies all have promising outcome in the treatment of tumor, some shortages are still unaddressed, such as the specificity of responsive is not good enough, and the active targeting may be diminished by the protein corona. Thus more research is required to promote the drug delivery study.

Prodrug Strategy for Cancer Cell-Specific Targeting: A Recent Overview

Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment

Prodrugs for Improving Tumor Targetability and Efficiency.

The Application of Prodrug-based Drug Delivery Strategy in Anticancer Drugs

Recent Advances in Small Molecule Prodrugs for Cancer Therapy

Cancer Cell‐Specific Fluorescent Prodrug Delivery Platforms

Advancements of prodrug technologies for enhanced drug selectivity in pharmacotherapies

Emerging Strategies in Stimuli-Responsive Prodrug Nanosystems for Cancer Therapy

Stimuli‐Responsive Prodrug Chemistries for Cancer Therapy

Bioorthogonal Chemistry-Based Prodrug Strategies for Enhanced Biosafety in Tumor Treatments: Current Progress and Challenges

Nanoparticulation of Prodrug into Medicines for Cancer Therapy

Polymer-Based Prodrugs For Cancer Chemotherapy

Stimulus-responsive Self-Assembled Prodrugs in Cancer Therapy

The Application of Prodrug-Based Nano-Drug Delivery Strategy in Cancer Combination Therapy

Polyprodrug Nanomedicines: an Emerging Paradigm for Cancer Therapy

Stimuli-responsive Polyprodrug for Cancer Therapy

The Design of Small-Molecule Prodrugs and Activatable Phototherapeutics for Cancer Therapy.

[The Development of Novel Tumor Targeting Delivery Strategy].

Engineering Prodrug Nanomedicine for Cancer Immunotherapy

Prodrug Strategies for Critical Drug Developability Issues: Part II

Exploring treatment options in cancer: Tumor treatment strategies